Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report

Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report

Kazuhito Misawa,1 Shinji Nakamichi,1 Hiroki Iida,1 Atsuhiro Nagano,1 Erika Mikami,1 Takehiro Tozuka,1 Masaru Matsumoto,1 Akihiko Miyanaga,1 Rintaro Noro,1 Kaoru Kubota,1 Hiroki Yamaguchi,2 Masahiro Seike1 1Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical Sch...

Full description

Bibliographic Details
Main Authors: Misawa K, Nakamichi S, Iida H, Nagano A, Mikami E, Tozuka T, Matsumoto M, Miyanaga A, Noro R, Kubota K, Yamaguchi H, Seike M
Format: Article
Language:English
Published: Dove Medical Press 2023-01-01
Series:OncoTargets and Therapy
Subjects:
non-small cell lung cancer
alk
alectinib
drug-induced hemolytic anemia
Online Access:https://www.dovepress.com/alectinib-induced-severe-hemolytic-anemia-in-a-patient-with-alk-positi-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/alectinib-induced-severe-hemolytic-anemia-in-a-patient-with-alk-positi-peer-reviewed-fulltext-article-OTT

Similar Items